No significant differences between medications for episodic migraine prophylaxis
1. In this systematic review and meta-analysis, there were no significant differences between various pharmacologic treatments for preventing episodic migraine ...
1. In this systematic review and meta-analysis, there were no significant differences between various pharmacologic treatments for preventing episodic migraine ...
1. In this retrospective cohort study, exposure to antiseizure medications was associated with a higher incidence of autism spectrum disorder ...
1. In this population-based cohort study, prenatal exposure to topiramate and valproate monotherapy was associated with increased risk of autism ...
1. 12-month remission was superior with valproate than with levetiracetam. 2. Compared to levetiracetam, patients in the valproate group reported ...
Image: PD 1. Maternal valproate use is associated with an increased risk of autism and other autism spectrum disorders in ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.